Author = Sherif Alrefai
| Number of Articles: 2 | ||
| 1 | Third line Treatment in Relapsed/Refractory Hodgkin's Lymphoma and Aggressive non-Hodgkin Lymphoma after 2nd line ESHAP or GEMOX | |
| Volume 14, Issue 1, June 2018, Page 17-20 | ||
| Hamdy Zawam; Wael Edesa; Sherif Alrefai; Ahmed Abdelhafeez | ||
| 2 | ESHAP versus GEMOX in Management of Relapsed or Refractory Lymphoma: A Prospective Randomized Study | |
| Volume 14, Issue 1, June 2018, Page 12-16 | ||
| Hamdy Zawam; Wael Edesa; Sherif Alrefai; Rasha Salama; Ahmed Abdelhafeez | ||
View on SCiNiTO